Fifth Third Wealth Advisors LLC bought a new position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 5,775 shares of the company's stock, valued at approximately $519,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. State Street Corp increased its stake in DocuSign by 2.3% during the 3rd quarter. State Street Corp now owns 5,372,939 shares of the company's stock worth $333,604,000 after acquiring an additional 120,743 shares during the period. Pacer Advisors Inc. increased its position in shares of DocuSign by 77.9% in the second quarter. Pacer Advisors Inc. now owns 3,519,969 shares of the company's stock worth $188,318,000 after purchasing an additional 1,541,816 shares during the period. Geode Capital Management LLC raised its stake in DocuSign by 1.6% in the third quarter. Geode Capital Management LLC now owns 3,483,184 shares of the company's stock valued at $215,789,000 after purchasing an additional 53,554 shares in the last quarter. Clearbridge Investments LLC lifted its position in DocuSign by 4.1% during the second quarter. Clearbridge Investments LLC now owns 2,920,842 shares of the company's stock worth $156,265,000 after purchasing an additional 115,616 shares during the period. Finally, Thrivent Financial for Lutherans grew its stake in DocuSign by 5.2% during the third quarter. Thrivent Financial for Lutherans now owns 2,277,312 shares of the company's stock worth $141,398,000 after buying an additional 112,919 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
DOCU has been the subject of a number of recent analyst reports. JMP Securities reaffirmed a "market outperform" rating and set a $124.00 price target on shares of DocuSign in a report on Tuesday, January 7th. Wells Fargo & Company upped their target price on DocuSign from $50.00 to $70.00 and gave the stock an "underweight" rating in a research note on Friday, December 6th. Morgan Stanley lifted their price target on DocuSign from $62.00 to $97.00 and gave the company an "equal weight" rating in a research note on Friday, December 6th. Royal Bank of Canada reissued a "sector perform" rating and set a $90.00 price target (up previously from $57.00) on shares of DocuSign in a report on Friday, December 6th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of DocuSign in a research note on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, DocuSign currently has an average rating of "Hold" and an average price target of $92.45.
Read Our Latest Stock Analysis on DOCU
DocuSign Stock Down 1.7 %
Shares of DOCU stock traded down $1.56 during mid-day trading on Friday, reaching $89.60. 2,379,686 shares of the stock traded hands, compared to its average volume of 2,200,838. The company has a market cap of $18.10 billion, a price-to-earnings ratio of 18.47, a price-to-earnings-growth ratio of 8.17 and a beta of 0.88. The stock's fifty day simple moving average is $88.76 and its two-hundred day simple moving average is $70.15. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86.
Insider Buying and Selling
In other news, Director Peter Solvik sold 10,000 shares of the firm's stock in a transaction on Friday, January 10th. The shares were sold at an average price of $91.26, for a total transaction of $912,600.00. Following the completion of the transaction, the director now owns 150,253 shares of the company's stock, valued at approximately $13,712,088.78. This trade represents a 6.24 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Allan C. Thygesen sold 7,764 shares of DocuSign stock in a transaction on Friday, November 1st. The stock was sold at an average price of $69.95, for a total transaction of $543,091.80. Following the transaction, the chief executive officer now owns 107,825 shares in the company, valued at approximately $7,542,358.75. This trade represents a 6.72 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 693,537 shares of company stock worth $66,575,817 in the last ninety days. Company insiders own 1.66% of the company's stock.
DocuSign Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.